Melissa Little

Last updated

Melissa Little

AC FAA FAHMS
Melissa Little 2017-002.jpg
Born(1963-12-05)5 December 1963
Brisbane, Australia
Nationality Australian
Alma mater
Known forDeveloping the world's first kidney in a dish
Scientific career
Fields Nephrology Stem Cell Organoids
Institutions University of Copenhagen, Murdoch Children's Research Institute
Doctoral advisor Peter Smith

Professor Melissa Little AC FAA FAHMS is an Australian scientist and academic, currently Theme Director of Cell Biology, heading up the Kidney Regeneration laboratory at the Murdoch Children's Research Institute. [1] She is also a Professor in the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and Program Leader of Stem Cells Australia. [2] In January 2022, she became CEO of the Novo Nordisk Foundation Center for Stem Cell Medicine reNEW, an international stem cell research center based at University of Copenhagen, and a collaboration between the University of Copenhagen, Denmark, Murdoch Children’s Research Institute, Australia, and Leiden University Medical Center, The Netherlands. [3]

Contents

She is internationally recognized both for her work on the systems biology of kidney development and also for her pioneering studies into potential regenerative therapies in the kidney. [4] [5] In 2015, Professor Melissa Little and her team at Murdoch Children’s Research Institute produced the world’s first kidney in a dish. [6] Known today as kidney organoids, this research has become a foundation of ongoing work to find a regenerative solution for kidney disease.

Early life and education

Melissa Little was born in Brisbane, Australia on 5 December 1963, the middle daughter of three girls. Her father, Ian Little, was a soils chemist with the CSIRO Cunningham laboratories. She graduated from Kenmore State High School in 1980. She completed her BSc at the University of Queensland with 1st Class Honours in Physiology in 1984. Her PhD studies were performed in the laboratory of Professor Peter Smith at the Queensland Institute of Medical Research enrolled through Biochemistry at the University of Queensland (conferred 1990). An alumnus of The University of Queensland, Brisbane, Australia, Melissa worked for more than 20 years at the Institute for Molecular Bioscience, where her research focused on the molecular basis of kidney development, renal disease and repair. In 2004 she graduated from the Australian Institute of Company Directors.[ citation needed ]

Research on kidney development, disease and regeneration

Little started her research career studying Wilm's Tumour, a childhood kidney cancer. She was awarded a Royal Society Endeavour Fellowship to move to the Medical Research Council Human Genetics Unit in Edinburgh to undertake postdoctoral training with Nicholas Hastie. Here she worked on the gene WT1, the gene that is mutated in a subset of Wilm's tumour patients.

She returned to Australia to continue to work on WT1, but concentrating on its essential role in the normal development of the urogenital system. [7] Her work focuses on the molecular aspects of kidney development, with applications to stem cell biology and regenerative medicine.

Little and her team have developed an approach to recapitulate nephrogenesis, the formation of nephrons, in a dish. By knowing where the different kidney cells come from and how they develop she has developed a system to regenerate them from pluripotent stem cells. Using embryonic stem cells, or induced pluripotent stem cells from a patient, her group has described a cocktail of growth factors that can drive development into kidney cells.

The group were able to develop self organising organoids 7mm long over 18 days. [8] [9] These small balls of cells have differentiated most of the cells that form the kidneys, including collecting ducts, podocytes, vasculature cells, nephrons and loops of Henle, and are closely related transcriptionallly to first and second trimester developing kidneys. Further research into the organoids by Prof Little's Laboratory has demonstrated robust transcriptional reproducibility of the model [10] and utilised induced pluripotent stem cells generated from patients to study their kidney disease. [11] [12]

Contributions to Australian Science policy

In the late 1990s, Little was a member of the Strategic Review of Health and Medical Research, chaired by Peter Wills. [13] This review [14] proposed a Virtuous Cycle between research, government and the commercial sector . As a result of these recommendations, the budget of the National Health and Medical Research Council was doubled over the next 10 years. She went on to serve on the Implementation Committee of that review and served under Robin Batterham, Chief Scientist, to identify strategic priorities across Australian science. A member of the NHMRC Research Committee for 6 years, she was also a member of the most recent review of health and medical research, chaired by Simon McKeon, which led to the establishment of the Medical Research Future Fund [15] and the Biomedical Translation Fund. [16]

Professional associations

Little is the 2021-2022 President of the International Society for Stem Cell Research [17] and Program Leader of Stem Cells Australia, [18] an organisation that aims to "Bring together Australia's premier life scientists to tackle the big questions in stem cell science". She is also a guest editor with the scientific journal Development. [19] She is the serving theme director of Cell Biology [20] at the Murdoch Childrens Research Institute and directs the MCRI Stem Cell Medicine Strategic Priority area. She is also the President of the Australasian Society for Stem Cell Research and a Board Member of the International Society for Stem Cell Research.

Awards and honours [21]

Related Research Articles

<span class="mw-page-title-main">Organoid</span> Miniaturized and simplified version of an organ

An organoid is a miniaturized and simplified version of an organ produced in vitro in three dimensions that shows realistic micro-anatomy. They are derived from one or a few cells from a tissue, embryonic stem cells or induced pluripotent stem cells, which can self-organize in three-dimensional culture owing to their self-renewal and differentiation capacities. The technique for growing organoids has rapidly improved since the early 2010s, and it was named by The Scientist as one of the biggest scientific advancements of 2013. Organoids are used by scientists to study disease and treatments in a laboratory.

The Australian Stem Cell Centre is an Australian medical research and development centre which focuses on regenerative medicine through the use of stem cells. Founded in 2003, the Centre is the National Biotechnology Centre of Excellence and has received over $100 million in funding in recent years. It is Australia's premier stem cell research organisation.


STEMCELL Technologies Inc., often abbreviated to STEMCELL, is a Canadian biotechnology company that develops, manufactures, and sells scientific instruments, reagents, and consumables. The company also markets education, custom manufacturing, and contract assay services for academic and industrial scientists.

<span class="mw-page-title-main">IFT140</span> Protein-coding gene in the species Homo sapiens

IFT140, Intraflagellar transport 140 homolog, is a protein that in humans is encoded by the IFT140 gene. The gene product forms a core component of IFT-A complex which is indipensible for retrograde intraflagellar transport within the primary cilium.

Amanda Jane Fosang is a biomedical researcher who has pioneered arthritis research in Australia.

<span class="mw-page-title-main">Josephine Forbes</span> Australian scientist

Josephine Forbes is an Australian scientist specialising in the study of glycation and diabetes. She has been studying diabetes since 1999 and has worked at Royal Children's Hospital, University of Melbourne and Baker Heart and Diabetes Institute in Melbourne Australia. Since 2012 she has led the Glycation and Diabetes team at Mater Research which is a world-class medical research institute based at South Brisbane, and part of the Mater Group. Josephine is program leader for Mater's Chronic Disease Biology and Care theme, building greater understanding of the biological basis of a broad range of chronic diseases, and developing preventative strategies and innovative treatments to improve patient outcomes. Josephine and her team focus on how advanced glycation contributes to the pathogenesis of diabetes and its complications such as kidney disease.

<span class="mw-page-title-main">Jane Visvader</span> Australian academic

Jane Visvader is a scientist specialising in breast cancer research who works for the Walter and Eliza Hall Institute in Melbourne, Australia. She is the joint head of the Breast Cancer Laboratory with Geoff Lindeman.

<span class="mw-page-title-main">Jeanne Loring</span> American biologist

Jeanne Frances Loring is an American stem cell biologist, developmental neurobiologist, and geneticist. She is the founding Director of the Center for Regenerative Medicine and emeritus professor at the Scripps Research Institute in La Jolla, California. She has founded two biotechnology companies, Arcos BioScience (1999) and Aspen Neuroscience (2018)

Professor Anne Kelso is an Australian biomedical researcher specialising in immunology and influenza. She is the Chief Executive Officer of the Australian Government's National Health and Medical Research Council (NHMRC).

<span class="mw-page-title-main">Marguerite Evans-Galea</span> Molecular biologist and advocate for women in STEMM

Marguerite Virginia Evans-Galea is the co-founder and CEO of Women in STEMM Australia. STEMM. Her research is focused on gene therapy and neurodegenerative diseases.

Katrina Jane Allen is an Australian politician and former medical researcher who was a member of the House of Representatives from 2019 until 2022. She is a member of the Liberal Party and represented the Division of Higgins in Victoria

Dr. Misty R. Jenkins is an Australian scientist known for her research into lymphocytes and cancer treatment.

Professor Susan J. Clark is an Australian biomedical researcher in epigenetics of development and cancer. She was elected a Fellow of the Australian Academy of Science in 2015, and is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow and Research Director and Head of Genomics and Epigenetics Division at the Garvan Institute of Medical Research. Clark developed the first method for bisulphite sequencing for DNA methylation analysis and used it to establish that the methylation machinery of mammalian cells is capable of both maintenance and de novo methylation at CpNpG sites and showed is inheritable. Clark's research has advanced understanding of the role of DNA methylation, non-coding RNA and microRNA in embryogenesis, reprogramming, stem cell development and cancer and has led to the identification of epigenomic biomarkers in cancer. Clark is a founding member of the International Human Epigenome Consortium (IHEC) and President of the Australian Epigenetics Alliance (AEpiA).

<span class="mw-page-title-main">Christine L. Mummery</span>

Christine L. Mummery (1953) is an appointed professor of Developmental Biology at Leiden University and the head of the Department of Anatomy and Embryology at Leiden University Medical Center in the Netherlands.

Paola Arlotta is the Golub Family Professor of Stem Cell and Regenerative Biology at Harvard University and chair of the Harvard Stem Cell and Regenerative Biology (HSCRB). Her research focuses on the development of neuron types in the cerebral cortex. She is best known for her work using 3D cerebral organoids derived from human induced pluripotent stem cells (iPSCs) to study cortical development in neurodegenerative and neuropsychiatric disorders.

<span class="mw-page-title-main">Milica Radisic</span> Serbian Canadian tissue engineer

Milica Radisic is a Serbian Canadian tissue engineer, academic and researcher. She is a professor at the University of Toronto’s Institute of Biomaterials and Biomedical Engineering, and the Department of Chemical Engineering and Applied Chemistry. She co-founded TARA Biosystems and is a senior scientist at the Toronto General Hospital Research Institute.

Jenny Hsieh is an American cell biologist and Semmes Foundation professor at the University of Texas at San Antonio (UTSA). Her work focuses on epilepsy and stem cell biology.

Samira Musah is an American biomedical engineer and professor at the Duke University Pratt School of Engineering. She is known for her work in biomimetic systems, in particular for her work in developing an organ-on-a-chip model of the kidney glomerulus during her postdoctoral fellowship.

Asha Bowen is an Australian pediatric infectious diseases clinician-scientist and associate professor, who is a leading voice and advocate for children's health and well-being.

Julie Bines, is a clinician and researcher working in Melbourne, Australia. Alongside being a professor and deputy head of the Department of Paediatrics at the University of Melbourne, she is also a paediatric gastroenterologist at the Royal Children's Hospital Melbourne and is the leader of the Enteric Diseases group at the Murdoch Children's Research Institute. Bines is the joint head of the WHO Collaborative Centre for Child Health and founding member of Women in Global Health Australia.

References

  1. ↑ "Professor Melissa Little | Murdoch Children's Research Institute". www.mcri.edu.au. Retrieved 25 July 2019.
  2. ↑ "Pursuit University of Melbourne".
  3. ↑ "New international research center to drive future stem cell-derived medicines"./
  4. 1 2 "Leiden Honorary Doctorates for Melissa Little and Robbert Dijkgraaf". Leiden University. Retrieved 8 February 2019.
  5. 1 2 Braybrook, Helen (16 April 2019). "Prof. Melissa Little receives international award for achievements in kidney research". School of Biomedical Sciences. Retrieved 25 July 2019.
  6. ↑ "News". www.stemcellsaustralia.edu.au. Retrieved 25 July 2019.
  7. ↑ Vicente, Catarina (15 March 2016). "An interview with Little". Development. 143 (6): 907–909. doi: 10.1242/dev.135897 . ISSN   0950-1991. PMID   26980790.
  8. ↑ Takasato, Minoru; Little, Melissa H. (15 December 2016). "A strategy for generating kidney organoids: Recapitulating the development in human pluripotent stem cells". Developmental Biology. The Development of Stem Cell-derived Organoids. 420 (2): 210–220. doi:10.1016/j.ydbio.2016.08.024. PMC   6186756 . PMID   27565022.
  9. ↑ Takasato, Minoru; Er, Pei X.; Chiu, Han S.; Maier, Barbara; Baillie, Gregory J.; Ferguson, Charles; Parton, Robert G.; Wolvetang, Ernst J.; Roost, Matthias S. (22 October 2015). "Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis". Nature. 526 (7574): 564–568. Bibcode:2015Natur.526..564T. doi:10.1038/nature15695. ISSN   0028-0836. PMID   26444236. S2CID   4443766.
  10. ↑ Phipson, Belinda; Er, Pei X; Combes, Alexander N; Forbes, Thomas A; Howden, Sara E; Zappia, Luke; et al. (January 2019). "Evaluation of variability in human kidney organoids". Nature Methods. 16 (1): 79–87. doi:10.1038/s41592-018-0253-2. ISSN   1548-7105. PMC   6634992 . PMID   30573816.
  11. ↑ Forbes, Thomas A.; Howden, Sara E.; Lawlor, Kynan; Phipson, Belinda; Maksimovic, Jovana; Hale, Lorna; Wilson, Sean; Quinlan, Catherine; Ho, Gladys (3 May 2018). "Patient-iPSC-Derived Kidney Organoids Show Functional Validation of a Ciliopathic Renal Phenotype and Reveal Underlying Pathogenetic Mechanisms". American Journal of Human Genetics. 102 (5): 816–831. doi:10.1016/j.ajhg.2018.03.014. ISSN   0002-9297. PMC   5986969 . PMID   29706353.
  12. ↑ Hale, Lorna J.; Howden, Sara E.; Phipson, Belinda; Lonsdale, Andrew; Er, Pei X.; Ghobrial, Irene; Hosawi, Salman; Wilson, Sean; Lawlor, Kynan T. (4 December 2018). "3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening". Nature Communications. 9 (1): 5167. Bibcode:2018NatCo...9.5167H. doi:10.1038/s41467-018-07594-z. ISSN   2041-1723. PMC   6279764 . PMID   30514835.
  13. ↑ "Peter Wills AC – RESEARCH AUSTRALIA". RESEARCH AUSTRALIA. Retrieved 28 September 2017.
  14. ↑ Health and Medical Research Strategic Review (Australia). Implementation Committee; Wills, Peter (2000). "Enabling the virtuous cycle" : Implementation Committee report / Health and Medical Research Strategic Review. [Canberra: Department of Health and Aged Care].
  15. ↑ "Further information on the Medical Research Future Fund". www.health.gov.au. Retrieved 28 September 2017.
  16. ↑ Commission, Australian Trade. "A$250 million Biomedical Translation Fund to bridg". www.austrade.gov.au. Retrieved 28 September 2017.
  17. ↑ "Melissa H. Little Assumes New Role as President of the ISSCR". www.isscr.org. Retrieved 7 November 2021.
  18. ↑ "Welcome to Stem Cells Australia". www.stemcellsaustralia.edu.au. Retrieved 29 August 2017.
  19. ↑ Vicente, Catarina (15 March 2016). "An interview with Melissa Little". Development. 143 (6): 907–909. doi: 10.1242/dev.135897 . ISSN   0950-1991. PMID   26980790.
  20. ↑ "Cell Biology | Murdoch Childrens Research Institute". www.mcri.edu.au. Retrieved 29 August 2017.
  21. ↑ "Professor Melissa Little | Murdoch Childrens Research Institute". www.mcri.edu.au. Retrieved 25 August 2017.
  22. ↑ "Australia Day 2023 Honours: Full list". The Sydney Morning Herald. 25 January 2023. Retrieved 25 January 2023.
  23. ↑ "2021 Award Recipients". American Society of Nephrology. 16 April 2019. Retrieved 7 September 2021.
  24. ↑ "Honour for outstanding contribution to understanding genes controlling kidney". School of Biomedical Sciences. 18 February 2020. Archived from the original on 7 September 2021. Retrieved 7 September 2020.
  25. ↑ Dean, Tim. "The 2016 Eureka Prizes showcase the best in Australian science". The Conversation. Retrieved 25 August 2017.
  26. ↑ "Fellowship of the Australian Academy of Health & Medical Sciences – October 2015" (PDF). Australian Academy of Health & Medical Sciences. Retrieved 12 October 2018.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.